Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Anticancer Research|November 29, 2025
Prognostic Value of Tertiary Lymphoid Structures in Epithelial Ovarian CarcinomaTakehiro Nakao, Kenichi Harano, Masashi Wakabayashi, et al.
International Journal of Clinical Oncology|June 22, 2026
Pain response to palliative intent conventional radiotherapy for painful malignant iliopsoas involvement: a multicenter retrospective studyKenji Makita, Yojiro Ishikawa, Yuki Wada, et al.
International Journal of Clinical Oncology|July 22, 2026
Pain response to re-irradiation for non-bone metastatic lesions: a single-institution retrospective studyKenji Makita, Yuichi Hiroshima, Masaki Nakamura, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 30, 2021
Predicting pathological lymph node status in clinical stage IA peripheral lung adenocarcinomaKeiju Aokage, Kenji Suzuki, Masashi Wakabayashi, et al.
JTCVS Open|August 25, 2022
A phase III study of adjuvant chemotherapy in patients with completely resected, node-negative non-small cell lung cancer (JCOG 0707)Hideo Kunitoh, Masahiro Tsuboi, Masashi Wakabayashi, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 27, 2020
Prognostic impact of a ground-glass opacity component in clinical stage IA non-small cell lung cancerAritoshi Hattori, Kenji Suzuki, Kazuya Takamochi, et al.
Japanese Journal of Clinical Oncology|July 21, 2020
A multi-institutional randomized phase III trial comparing anatomical segmentectomy and wedge resection for clinical stage IA non-small cell lung cancer in high-risk operable patients: Japan Clinical Oncology Group Study JCOG1909 (ANSWER study)Ryo Shimoyama, Yasuhiro Tsutani, Masashi Wakabayashi, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 19, 2020
Long-term survival outcome after lobectomy in patients with clinical T1 N0 lung cancerHiroyuki Ito, Kenji Suzuki, Tomonori Mizutani, et al.
Japanese Journal of Clinical Oncology|May 22, 2021
Prospective evaluation of watchful waiting for early-stage lung cancer with ground-glass opacity: a single-arm confirmatory multicenter study: Japan Clinical Oncology Group study JCOG1906 (EVERGREEN study)Tomohiro Miyoshi, Keiju Aokage, Masashi Wakabayashi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2021
Prognostic influence of epidermal growth factor receptor mutation and radiological ground glass appearance in patients with early-stage lung adenocarcinomaKeiju Aokage, Tomohiro Miyoshi, Masashi Wakabayashi, et al.
Pageof 15